New Results
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
Kathryn Westendorf, Lingshu Wang, Stefanie Žentelis, Denisa Foster, Peter Vaillancourt, Matthew Wiggin, Erica Lovett, Robin van der Lee, Jörg Hendle, Anna Pustilnik, J. Michael Sauder, Lucas Kraft, Yuri Hwang, Robert W. Siegel, Jinbiao Chen, Beverly A. Heinz, Richard E. Higgs, Nicole Kallewaard, Kevin Jepson, Rodrigo Goya, Maia A. Smith, David W. Collins, Davide Pellacani, Ping Xiang, Valentine de Puyraimond, Marketa Ricicova, Lindsay Devorkin, Caitlin Pritchard, Aoise O’Neill, Kush Dalal, Pankaj Panwar, Harveer Dhupar, Fabian A. Garces, Courtney Cohen, John Dye, Kathleen E. Huie, Catherine V. Badger, Darwyn Kobasa, Jonathan Audet, Joshua J. Freitas, Saleema Hassanali, Ina Hughes, Luis Munoz, Holly C. Palma, Bharathi Ramamurthy, Robert W. Cross, Thomas W. Geisbert, Vineet Menacherry, Kumari Lokugamage, Viktoriya Borisevich, Iliana Lanz, Lisa Anderson, Payal Sipahimalani, Kizzmekia S. Corbett, Eun Sung Yang, Yi Zhang, Wei Shi, Tongqing Zhou, Misook Choe, John Misasi, Peter D. Kwong, Nancy J. Sullivan, Barney S. Graham, Tara L. Fernandez, Carl L. Hansen, Ester Falconer, John R. Mascola, Bryan E. Jones, Bryan C. Barnhart
doi: https://doi.org/10.1101/2021.04.30.442182
Kathryn Westendorf
1AbCellera Biologics Inc., Vancouver, BC, Canada
Lingshu Wang
2Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Stefanie Žentelis
1AbCellera Biologics Inc., Vancouver, BC, Canada
Denisa Foster
3Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Peter Vaillancourt
3Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Matthew Wiggin
1AbCellera Biologics Inc., Vancouver, BC, Canada
Erica Lovett
1AbCellera Biologics Inc., Vancouver, BC, Canada
Robin van der Lee
1AbCellera Biologics Inc., Vancouver, BC, Canada
Jörg Hendle
3Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Anna Pustilnik
3Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
J. Michael Sauder
2Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Lucas Kraft
1AbCellera Biologics Inc., Vancouver, BC, Canada
Yuri Hwang
1AbCellera Biologics Inc., Vancouver, BC, Canada
Robert W. Siegel
4Eli Lilly and Company, Indianapolis, IN, USA
Jinbiao Chen
4Eli Lilly and Company, Indianapolis, IN, USA
Beverly A. Heinz
4Eli Lilly and Company, Indianapolis, IN, USA
Richard E. Higgs
4Eli Lilly and Company, Indianapolis, IN, USA
Nicole Kallewaard
4Eli Lilly and Company, Indianapolis, IN, USA
Kevin Jepson
1AbCellera Biologics Inc., Vancouver, BC, Canada
Rodrigo Goya
1AbCellera Biologics Inc., Vancouver, BC, Canada
Maia A. Smith
1AbCellera Biologics Inc., Vancouver, BC, Canada
David W. Collins
1AbCellera Biologics Inc., Vancouver, BC, Canada
Davide Pellacani
1AbCellera Biologics Inc., Vancouver, BC, Canada
Ping Xiang
1AbCellera Biologics Inc., Vancouver, BC, Canada
Valentine de Puyraimond
1AbCellera Biologics Inc., Vancouver, BC, Canada
Marketa Ricicova
1AbCellera Biologics Inc., Vancouver, BC, Canada
Lindsay Devorkin
1AbCellera Biologics Inc., Vancouver, BC, Canada
Caitlin Pritchard
1AbCellera Biologics Inc., Vancouver, BC, Canada
Aoise O’Neill
1AbCellera Biologics Inc., Vancouver, BC, Canada
Kush Dalal
1AbCellera Biologics Inc., Vancouver, BC, Canada
Pankaj Panwar
1AbCellera Biologics Inc., Vancouver, BC, Canada
Harveer Dhupar
1AbCellera Biologics Inc., Vancouver, BC, Canada
Fabian A. Garces
1AbCellera Biologics Inc., Vancouver, BC, Canada
Courtney Cohen
5U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, 21702, USA
John Dye
5U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, 21702, USA
Kathleen E. Huie
5U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, 21702, USA
Catherine V. Badger
5U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, 21702, USA
Darwyn Kobasa
6National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
7University of Manitoba, Winnipeg, Manitoba, Canada
Jonathan Audet
6National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
7University of Manitoba, Winnipeg, Manitoba, Canada
Joshua J. Freitas
3Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Saleema Hassanali
3Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Ina Hughes
3Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Luis Munoz
3Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Holly C. Palma
3Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Bharathi Ramamurthy
3Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Robert W. Cross
7University of Manitoba, Winnipeg, Manitoba, Canada
8Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA
Thomas W. Geisbert
7University of Manitoba, Winnipeg, Manitoba, Canada
8Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA
Vineet Menacherry
8Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA
Kumari Lokugamage
8Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA
Viktoriya Borisevich
8Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA
Iliana Lanz
1AbCellera Biologics Inc., Vancouver, BC, Canada
Lisa Anderson
1AbCellera Biologics Inc., Vancouver, BC, Canada
Payal Sipahimalani
1AbCellera Biologics Inc., Vancouver, BC, Canada
Kizzmekia S. Corbett
2Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Eun Sung Yang
2Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Yi Zhang
2Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Wei Shi
2Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Tongqing Zhou
2Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Misook Choe
2Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
John Misasi
2Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Peter D. Kwong
2Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Nancy J. Sullivan
2Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Barney S. Graham
2Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Tara L. Fernandez
1AbCellera Biologics Inc., Vancouver, BC, Canada
Carl L. Hansen
1AbCellera Biologics Inc., Vancouver, BC, Canada
Ester Falconer
1AbCellera Biologics Inc., Vancouver, BC, Canada
John R. Mascola
2Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Bryan E. Jones
3Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Bryan C. Barnhart
1AbCellera Biologics Inc., Vancouver, BC, Canada
Posted January 07, 2022.
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
Kathryn Westendorf, Lingshu Wang, Stefanie Žentelis, Denisa Foster, Peter Vaillancourt, Matthew Wiggin, Erica Lovett, Robin van der Lee, Jörg Hendle, Anna Pustilnik, J. Michael Sauder, Lucas Kraft, Yuri Hwang, Robert W. Siegel, Jinbiao Chen, Beverly A. Heinz, Richard E. Higgs, Nicole Kallewaard, Kevin Jepson, Rodrigo Goya, Maia A. Smith, David W. Collins, Davide Pellacani, Ping Xiang, Valentine de Puyraimond, Marketa Ricicova, Lindsay Devorkin, Caitlin Pritchard, Aoise O’Neill, Kush Dalal, Pankaj Panwar, Harveer Dhupar, Fabian A. Garces, Courtney Cohen, John Dye, Kathleen E. Huie, Catherine V. Badger, Darwyn Kobasa, Jonathan Audet, Joshua J. Freitas, Saleema Hassanali, Ina Hughes, Luis Munoz, Holly C. Palma, Bharathi Ramamurthy, Robert W. Cross, Thomas W. Geisbert, Vineet Menacherry, Kumari Lokugamage, Viktoriya Borisevich, Iliana Lanz, Lisa Anderson, Payal Sipahimalani, Kizzmekia S. Corbett, Eun Sung Yang, Yi Zhang, Wei Shi, Tongqing Zhou, Misook Choe, John Misasi, Peter D. Kwong, Nancy J. Sullivan, Barney S. Graham, Tara L. Fernandez, Carl L. Hansen, Ester Falconer, John R. Mascola, Bryan E. Jones, Bryan C. Barnhart
bioRxiv 2021.04.30.442182; doi: https://doi.org/10.1101/2021.04.30.442182
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
Kathryn Westendorf, Lingshu Wang, Stefanie Žentelis, Denisa Foster, Peter Vaillancourt, Matthew Wiggin, Erica Lovett, Robin van der Lee, Jörg Hendle, Anna Pustilnik, J. Michael Sauder, Lucas Kraft, Yuri Hwang, Robert W. Siegel, Jinbiao Chen, Beverly A. Heinz, Richard E. Higgs, Nicole Kallewaard, Kevin Jepson, Rodrigo Goya, Maia A. Smith, David W. Collins, Davide Pellacani, Ping Xiang, Valentine de Puyraimond, Marketa Ricicova, Lindsay Devorkin, Caitlin Pritchard, Aoise O’Neill, Kush Dalal, Pankaj Panwar, Harveer Dhupar, Fabian A. Garces, Courtney Cohen, John Dye, Kathleen E. Huie, Catherine V. Badger, Darwyn Kobasa, Jonathan Audet, Joshua J. Freitas, Saleema Hassanali, Ina Hughes, Luis Munoz, Holly C. Palma, Bharathi Ramamurthy, Robert W. Cross, Thomas W. Geisbert, Vineet Menacherry, Kumari Lokugamage, Viktoriya Borisevich, Iliana Lanz, Lisa Anderson, Payal Sipahimalani, Kizzmekia S. Corbett, Eun Sung Yang, Yi Zhang, Wei Shi, Tongqing Zhou, Misook Choe, John Misasi, Peter D. Kwong, Nancy J. Sullivan, Barney S. Graham, Tara L. Fernandez, Carl L. Hansen, Ester Falconer, John R. Mascola, Bryan E. Jones, Bryan C. Barnhart
bioRxiv 2021.04.30.442182; doi: https://doi.org/10.1101/2021.04.30.442182
Subject Area
Subject Areas
- Biochemistry (11718)
- Bioengineering (8724)
- Bioinformatics (29132)
- Biophysics (14936)
- Cancer Biology (12051)
- Cell Biology (17360)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14146)
- Epidemiology (2067)
- Evolutionary Biology (18269)
- Genetics (12223)
- Genomics (16768)
- Immunology (11844)
- Microbiology (28016)
- Molecular Biology (11560)
- Neuroscience (60822)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10401)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)